BB&T CORP 4

4 · BB&T CORP · Filed Jan 25, 2017

Form 4

Period: 2017-01-23

Sr. Exec. Vice President

Transactions

Sale
Common Stock
2017-01-23$45.47/sh−7,522$341,991→ 8,204 total
Exercise/Conversion
Stock Option (right to buy)
2017-01-23−2,294→ 0 total
Exercise: $30.09From: 2013-02-21Exp: 2022-02-21→ Common Stock (2,294 underlying)
Exercise/Conversion
Stock Option (right to buy)
2017-01-23−4,341→ 0 total
Exercise: $44.15From: 2008-02-20Exp: 2017-02-20→ Common Stock (4,341 underlying)
Exercise/Conversion
Common Stock
2017-01-23$30.09/sh+2,294$69,026→ 14,839 total
Exercise/Conversion
Common Stock
2017-01-23$27.73/sh+887$24,597→ 15,726 total
Exercise/Conversion
Common Stock
2017-01-23$44.15/sh+4,341$191,655→ 12,545 total
Exercise/Conversion
Stock Option (right to buy)
2017-01-23−887→ 0 total
Exercise: $27.73From: 2012-02-22Exp: 2021-02-22→ Common Stock (887 underlying)

Holdings

Footnotes (6)

[F1]The total does not include a fractional share of 0.822 that was disposed of for cash when the reporting person transferred shares from one account to another.
[F2]The price in Column 4 is a weighted average price. The prices actually received ranged from $45.4200 to $45.4950. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
[F3]Includes 2.041 shares acquired between July 1, 2016 and December 31, 2016, under the Issuer's 401(k) plan. The information in this report is based on plan statements dated July 1, 2016 through December 31, 2016.
[F4]The option is exercisable in five equal annual installments beginning on 2/20/2008.
[F5]The option is exercisable in four equal annual installments beginning on 02/21/2013.
[F6]The option is exercisable in four equal annual installments beginning on 2/22/2012.

Documents

1 file